Piopar-MF 15 Tablet ER
Marketer
Mitoch Pharma Pvt Ltd
Salt Composition
Pioglitazone (15mg) + Metformin (500mg)
Overview Piopar-MF 15 Tablet ER
Metformin and Pioglitazone extended-release tablets (15mg) manage blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and regimen. Take it with food to prevent gastric distress. If a dose is missed, take it promptly; otherwise, omit it and resume your usual schedule. Never double the dose; overdose may cause hypoglycemia. Common, usually mild, side effects include nausea, anorexia, altered taste, abdominal pain, diarrhea, and swelling. Consult your doctor if these persist or are concerning. Prior to use, disclose any kidney, liver, or heart conditions. Pregnant or lactating individuals should seek medical advice before use. Renal function will be assessed before commencing treatment. Limit alcohol consumption, as it might heighten adverse effects.
Uses of Piopar-MF 15 Tablet ER
Managing type 2 diabetes
Major Benefits of Piopar-MF 15 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Piopar-MF 15 Tablet ER with a meal.
Common Side effects of Piopar-MF 15 Tablet ER:
- Diarrhea
- Edema (swelling)
- Headache
- Nausea
- Vomiting
- Hypoglycemia (low blood glucose level)
- Dizziness
- Urinary tract infection
- Upper respiratory tract infection
- Sinus infection
How to use Piopar-MF 15 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Piopar-MF 15 Tablet ER with a meal.
How Piopar-MF 15 Tablet ER works:
Extended-release Piopar-MF 15 tablets contain a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Piopar-MF 15 Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Piopar-MF 15 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Piopar-MF 15 tablets are likely unsafe for breastfeeding mothers. Available evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Piopar-MF 15 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Piopar-MF 15 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Extended-release Piopar-MF 15 tablets require careful consideration in individuals with hepatic impairment. Dosage modification of Piopar-MF 15 ER may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, Piopar-MF 15 ER therapy typically commences with a reduced dosage; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Piopar-MF 15 Tablet ER :
Should you forget to take a Piopar-MF 15 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Piopar-MF 15 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
3,018 People bought this recently